BRIEF published on 12/17/2025 at 14:43, 1 month 22 days ago First Berlin Equity Research met à jour sa recommandation sur Cardiol Therapeutics, passant à « Acheter » avec un objectif de cours abaissé. Recommandation D'achat Ajustement Du Prix Cible Thérapeutique Cardiaque Étude ARCHER De Phase II Myocardite
BRIEF published on 12/17/2025 at 14:43, 1 month 22 days ago First Berlin Equity Research Updates Cardiol Therapeutics to "Buy" with a Lowered Target Price Buy Recommendation Target Price Adjustment Cardiol Therapeutics Phase II ARCHER Study Myocarditis
PRESS RELEASE published on 12/17/2025 at 14:38, 1 month 22 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc., lowering price target to USD 7.80 based on positive Phase II ARCHER data on CardiolRx for acute myocarditis First Berlin Equity Research Buy Recommendation Acute Myocarditis Cardiol Therapeutics Inc. Phase II ARCHER Data
BRIEF published on 10/23/2025 at 12:56, 3 months 17 days ago Cardiol Therapeutics Secures Funding with USD 11.4 Million Private Placement Private Placement Clinical Trials Financial Outlook Cardiol Therapeutics Heart-Failure Therapy
BRIEF published on 10/23/2025 at 12:56, 3 months 17 days ago Cardiol Therapeutics obtient un financement avec un placement privé de 11,4 millions de dollars Placement Privé Essais Cliniques Cardiol Therapeutics Perspectives Financières Traitement De L'insuffisance Cardiaque
PRESS RELEASE published on 10/23/2025 at 12:51, 3 months 17 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates Cardiol Therapeutics Inc with a BUY rating and USD 8.50 price target. The private placement secures funds for pivotal trials and new product development Private Placement Cardiol Therapeutics Inc First Berlin Equity Research BUY Rating USD 8.50 Price Target
BRIEF published on 08/12/2025 at 13:36, 5 months 27 days ago Cardiol Therapeutics : résultats de l'essai de phase II et perspectives boursières positives Cardiol Therapeutics Acheter Une Note CardiolRx Essai ARCHER De Phase II Myocardite Aiguë
BRIEF published on 08/12/2025 at 13:36, 5 months 27 days ago Cardiol Therapeutics: Phase II Trial Results and Positive Stock Outlook BUY Rating Cardiol Therapeutics CardiolRx Phase II ARCHER Trial Acute Myocarditis
PRESS RELEASE published on 08/12/2025 at 13:31, 5 months 27 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc after positive phase II trial results for CardiolRx in acute myocarditis Cardiol Therapeutics Inc First Berlin Equity Research Phase II Trial CardiolRx Acute Myocarditis
BRIEF published on 04/23/2025 at 15:29, 9 months 15 days ago Cardiol Therapeutics Advances in Pivotal Phase III Study FDA Approval Cardiol Therapeutics Phase III Study Recurrent Pericarditis CardiolRxT
Published on 02/09/2026 at 13:00, 21 minutes ago Eagle Plains' Partner Refined Energy Corp. Mobilizes Geophysical Team to the Dufferin West Project, Saskatchewan
Published on 02/09/2026 at 13:00, 21 minutes ago Abasca Resources Announces Assay Results from the Summer 2025 Drill Program and Start of Winter Drilling at its Loki Flake Graphite Deposit
Published on 02/09/2026 at 13:00, 21 minutes ago ATHA Energy Provides Post CAD $63 Million Financing Plans - Focused on Growth and Discovery at the Angilak Uranium Project
Published on 02/09/2026 at 12:30, 51 minutes ago Trans Canada Gold Corp. Grants Incentive Stock Options
Published on 02/09/2026 at 11:30, 1 hour 51 minutes ago FireFox Gold Expands the Northeast Zone, including 54.91 g/t Gold over 1.95 Metres in 95 Metre Step-out at Mustajärvi Gold Project, Finland
Published on 02/09/2026 at 11:45, 1 hour 36 minutes ago Ex-CBRE Paul Saville-King Appointed Group Chief Executive Officer at Unispace
Published on 02/09/2026 at 11:00, 2 hours 21 minutes ago Iute Group Reports Unaudited 12M 2025 Results on 19 February 2026 – Invitation to Earnings Webcast/Call on the Same Day
Published on 02/09/2026 at 10:40, 2 hours 41 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 02/09/2026 at 08:30, 4 hours 51 minutes ago THERMADOR GROUPE : Plan to separate the roles of chairman and chief executive officer
Published on 02/09/2026 at 08:30, 4 hours 51 minutes ago THERMADOR GROUPE : Projet de séparation des mandats de président et directeur général
Published on 02/09/2026 at 08:00, 5 hours 21 minutes ago Eiffage renforce son expertise dans le secteur du froid industriel avec une prise de participation majoritaire dans l’entreprise française Quercy Réfrigération
Published on 02/09/2026 at 08:00, 5 hours 21 minutes ago Eiffage strengthen its expertise in the industrial refrigeration sector with the acquisition of a majority holding in the French company Quercy Réfrigération
